Welcome to LookChem.com Sign In|Join Free

CAS

  • or

36107-02-5

Post Buying Request

36107-02-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

36107-02-5 Usage

General Description

5,7-Dibromoquinolin-8-amine is a chemical compound with the molecular formula C9H6Br2N2. It is a derivative of quinoline and contains two bromine atoms attached to the 5th and 7th carbon positions of the quinoline ring, with an amine group attached to the 8th carbon position. 5,7-Dibromoquinolin-8-amine is used in organic synthesis and medicinal chemistry for the development of new pharmaceuticals and biologically active molecules. Its unique structure and functional groups make it a valuable building block for the synthesis of various heterocyclic compounds with potential biological activities. Additionally, 5,7-Dibromoquinolin-8-amine has been found to exhibit antimicrobial and antiparasitic properties, making it a promising candidate for drug development.

Check Digit Verification of cas no

The CAS Registry Mumber 36107-02-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,1,0 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 36107-02:
(7*3)+(6*6)+(5*1)+(4*0)+(3*7)+(2*0)+(1*2)=85
85 % 10 = 5
So 36107-02-5 is a valid CAS Registry Number.

36107-02-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,7-dibromoquinolin-8-amine

1.2 Other means of identification

Product number -
Other names 5,7-Dibromo-quinolin-8-ylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:36107-02-5 SDS

36107-02-5Relevant articles and documents

Structural Diversity in a New Series of Halogenated Quinolyl Salicylaldimides-Based FeIII Complexes Showing Solid-State Halogen-Bonding/Halogen···Halogen Interactions

Ashoka Sahadevan, Suchithra,Cadoni, Enzo,Monni, Noemi,Sáenz De Pipaón, Cristina,Galan Mascaros, José-Ramon,Abhervé, Alexandre,Avarvari, Narcis,Marchiò, Luciano,Arca, Massimiliano,Mercuri, Maria Laura

, p. 4187 - 4199 (2018/06/11)

A new series of tridentate N-8-quinolyl-salicylaldimine ligands, Hqsal-5,7-X2 [X = Cl(1), Br(2), I(3)], halo-substituted at the 5,7 position of the aminoquinoline moiety and their corresponding complexes with FeIII were synthesized and formulated as [Fe(qsal-5,7-X2)(NCS)(MeO)]2·solv. (X = Cl (1a), Br (2a), I (3a, solv = 1/2MeOH), [Fe4(qsal-5,7-X2)4(NCS)2(MeO)2]·solv. (X = Br (2b), I (3b; solv = 4CH2Cl2)) by single-crystal X-ray diffraction analysis. 1a and 2a are isostructural dimers where each FeIII metal ion, showing a distorted octahedral environment, is bound by a N,N,O tridentate (qsal-5,7-X2)- (X = Cl and Br) ligand, a N-coordinated SCN- anion, and a bridging methanolate anion. 2b and 3b are centrosymmetric tetramers where each FeIII is bound by three nitrogen atoms and three oxygen atoms derived from a tridentate (qsal-5,7-X2)- (X = Br and I), a SCN-, a bridging methanolate anion, and a bridging μ2-oxy moiety. In 3b, the iodine atoms dominate the packing interactions through the establishment of a halogen-bonding network. The magnetic behavior of 1a-3a dimers and 2b-3b tetramers indicate the presence of strong antiferromagnetic interactions between FeIII centers (S = 5/2), mediated by the alkoxy bridges. Experimental data can be modeled with an isotropic Hamiltonian, H = -2J(S1 · S2) for dimers (J = -15 cm-1) and H = -2J(S2 · S3) - 2J′(S1 · S2 + S3 · S4), for tetramers (J = -24 cm-1, J′ = -11 cm-1). The magnetic behavior of 1a-3a dimers indicates the presence of strong antiferromagnetic interactions between FeIII centers (S = 5/2), mediated by the alkoxy bridges. 2b and 3b show the same magnetic behavior since they contains analogous bridges between paramagnetic centers, but for a linear tetramer. Density functional theory (DFT) calculations, based on hybrid functional mPW1PW paralleled by the Def2SVP all-electron split-valence basis sets, support the experimental results, showing that monomers could possibly show a spin crossover (SCO) behavior, even though the formation of complexes with an even number of metal ions results in the strong antiferromagnetic interactions. Accordingly, broken symmetry DFT calculations carried out on 1a clearly show that the antiferromagnetic coupling of the two HS FeIII centers results in the lowest energy electron configuration of the complex.

A SAR study: Evaluation of bromo derivatives of 8-substituted quinolines as novel anticancer agents

?kten, Salih,?akmak, Osman,Tekin, ?aban,K?prülü, Tu?ba Kul

, p. 1415 - 1424 (2017/12/28)

Background: Brominated 8-hydroxy, 8-methoxy, 8-amino quinolines 5, 6, 8, 9 and novel cyano 8-hydroxyquinolines 11, 12 were evaluated in vitro for their anticancer effects on various cell lines. 5, 7-Dibromo- 5, 7-bromo- 6, 7-cyano- 11 and 5, 7-dicyano-12 8-hydroxyquinolines were shown to have strong antiproliferative activity against various tumor cell lines, including C6 (rat brain tumor), HeLa (human cervix carcinoma), and HT29 (human colon carcinoma) with IC50 values ranged from 6.7 to 25.6 μg/mL. Methods: A structure activity relationship (SAR) was conducted that quinoline core containing hydroxly group at C-8 positon led to more anti cancer potentials. Results: The results of Lactate Dehydrogenase (LDH) cytotoxic, DNA laddering and inhibition assays indicated that 5, 6, 11 and 12 have high cytotoxic effects and appototic potentials. Conclusion: Furthermore, 5 and 12 have inhibitory effects on relaxation of supercoiled plazmid DNA by supressed the Topoisomerase I enzyme. As a result, 5, 6, 11 and 12 may have promising anticancer drug potential and 5 and 12 may be novel topoisomerase inhibitors.

Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides

da Silva, Luiz Everson,Joussef, Ant?nio Carlos,Pacheco, Letícia Kramer,da Silva, Daniela Gaspar,Steindel, Mário,Rebelo, Ricardo Andrade

, p. 7553 - 7560 (2008/03/28)

In the present paper 12 N-quinolin-8-yl-arylsulfonamides synthesized by coupling 8-aminoquinolines with various arylsulfonylchlorides were assayed in vitro against Leishmania amazonensis, Leishmania chagasi and Trypanosoma cruzi strains. This series of ne

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 36107-02-5